Biofarma Group agrees to Ardian bid

Ardian has agreed to buy a majority stake in Italian food-supplement maker Biofarma Group, in a deal said to be valued at €1.1 billion.

The private equity firm announced the acquisition from White Bridge Investments in a statement this morning, adding that Scarpa will retain its 30% stake in the group. The financial terms were not disclosed, but reports that first appeared from Reuters over the week put the deal at €1.1 billion, noting that Ardian fended off competition from BC Partners.

Nomura, BNP Paribas and Mediobanca were M&A advisers to Ardian. Houlihan Lokey was debt adviser.

Biofarma Group is the Italian and European leader in the development, manufacture and packaging of food supplements, medical devices, probiotic-based products and cosmetics.